Seer, Inc. SEER
1.61 USD -0.07 (-4.17%)
At closeNov 10, 2026, 4:00 PM EST
1.55 -0.06 -3.73%
After hours · Nov 10, 4:00 PM ET
1.57 Day range 1.71
1.55 52-week range 2.38
- YTD
- -12.02%
- 1 year
- -22.97%
News
seekingalpha.com Seer, Inc. (SEER) Q3 2026 Earnings Call Transcript Seer, Inc. (SEER) Q3 2026 Earnings Call Transcript
marketbeat.com Seer Q3 Earnings Call Highlights Seer NASDAQ: SEER lowered its 2026 revenue outlook after research funding constraints and uncertainty surrounding its future delayed customer purchases, even as third-quarter revenue rose from the…
benzinga.com Seer Q3 2026 Earnings Call Transcript Seer (NASDAQ:SEER) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
benzinga.com Seer Lowers FY2026 Sales Guidance from $16.000M-$18.000M to $13.500M-$14.500M vs $16.100M Est Seer (NASDAQ:SEER) lowers FY2026 sales outlook from $16.000 million-$18.000 million to $13.500 million-$14.500 million vs $16.100 million estimate.
benzinga.com Seer Q3 EPS $(0.25), Inline, Sales $3.981M Miss $4.150M Estimate Seer (NASDAQ:SEER) reported quarterly losses of $(0.25) per share which met the analyst consensus estimate. This is a 21.88 percent increase over losses of $(0.32) per share from the same period last…
globenewswire.com Seer Secures Key Victory in ITC Patent Dispute as Investigative Staff Backs All Requested Remedies Against Nanomics REDWOOD CITY, Calif., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced a significant victory in its…
benzinga.com Braden Leonard Reports 4.7% Stake In Seer As Of Nov 2 https://www.sec.gov/Archives/edgar/data/1373604/000137360426000071/xslSCHEDULE_13D_X02/primary_doc.xml
benzinga.com Seer Announces Its Board Rejects Proposed Acquisition Offers From Bradley L. Radoff And Michael Torok, Omid Farokhzad; Plans To Continue As Independent Entity Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the Special Committee of Seer’s Board of Directors (the "Special Committee") has…- benzinga.com Seer Q2 EPS $(0.31) Misses $(0.27) Estimate, Sales $3.100M Miss $3.550M Estimate Seer (NASDAQ:SEER) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.27) by 14.81 percent. This is a 6.06 percent increase over losses of $(0.33) per…
benzinga.com Seer Affirms FY2026 Sales Guidance of $16.000M-$18.000M vs $16.250M Est Seer (NASDAQ:SEER) affirms FY2026 sales outlook from $16.000 million-$18.000 million to $16.000 million-$18.000 million vs $16.250 million estimate.- benzinga.com Seer Receives Revised Acquisition Proposal From Radoff-JEC Group For $2.55 Per Share In Cash Plus A Contingent Value Right.; Special Committee To Review Both Acquisition Proposals And Other Alternatives Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today confirmed that on July 28, 2026, it received a further revised, unsolicited, non-binding…
benzinga.com Seer Receives Improved $2.55/Share Acquisition Proposal From 7.7% Stockholders Bradley L. Radoff and Michael Torok, The Radoff-JEC Group Proposal Provides Stockholders $2.55 per Share in Cash, a 51% Premium to the Unaffected Share Price and 29% Premium to the Current Share Price, as Well as Potential Additional Value from the Sale of…
benzinga.com Seer Special Committee Unanimously Rejects Unsolicited Takeover Proposal From Chair/CEO At $2.45 Per Share In Cash Plus Two CVRs Consistent with its fiduciary duties, the Special Committee carefully reviewed the Proposal in consultation with its independent advisors and unanimously determined that it is not in the best…
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers Innovative Eyewear (NASDAQ:LUCY) stock moved upwards by 95.4% to $1.49 during Monday's regular session. The market value of their outstanding shares is at $4.8 million. Seer (NASDAQ:SEER)…
benzinga.com Radoff-JEC Group Agrees With Seer CEO That It Should Not Be A Public Company; Advocates For Sale Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group" or "we"), who collectively own approximately 7.7% of the outstanding common stock of Seer, Inc.
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers Seer (NASDAQ:SEER) shares rose 32.1% to $2.14 during Monday's pre-market session. The market value of their outstanding shares is at $89.0 million. Innovative Eyewear (NASDAQ:LUCY) stock rose…- benzinga.com Market-Moving News for July 6th INTC: 3% | After Apple, Intel Raises Chip Prices by Up to $50, Citing 'Market Dynamics' SEER: 43% | Seer Highlights Strategic Progress, Urges Support For Board Nominees On Blue Card
- benzinga.com Seer Highlights Strategic Progress, Urges Support For Board Nominees On Blue Card Seer is Delivering Clear Progress Against its Strategic Plan and Maintaining Focus on Cost Discipline, Governance Rigor and Product Innovation Highly Qualified, Independent and Accountable Board Has…
benzinga.com Why Maison Solutions Shares Are Trading Higher By Over 62%; Here Are 20 Stocks Moving Premarket Maison Solutions (NASDAQ: MSS) rose 62.6% in pre-market trading after divesting some operations for $4.5 million. Gainers include ZCMD, FXHO, LHSW, YHC, SEER, SDOT, PEW, NUAI, SHAZ. Losers include…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session Gainers Seer (NASDAQ:SEER) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals…- benzinga.com Seer Receives An Unsolicited, Non-Binding Proposal From Omid Farokhzad, M.D., Seer’s Chair And Chief Executive Officer, To Acquire All Of The Outstanding Shares Of Seer’s Class A Common Stock For $2.45 Per Share In Cash Plus Two Separate Contingent Value Rights Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it has received an unsolicited, non-binding proposal from Omid Farokhzad, M.D.,…
- benzinga.com Seer Secures European Patent, U.S. International Trade Commission Probe Launched Into Alleged Nanomics Infringement Seer, Inc. (NASDAQ:SEER), a pioneer and trusted partner for deep, unbiased proteomic insights, today announced two significant developments that reinforce the strength of the intellectual property…
- benzinga.com Seer Board Pushes Back Against Activist Investor Campaign Seer, Inc. (NASDAQ:SEER) ("Seer" or the "Company") today issued a letter to stockholders containing important information for shareholders to consider in connection with the Company's upcoming Annual…
benzinga.com Seer Files Complaint Against Nanomics At The ITC, With Brigham And Women's Hospital Joining In The ITC complaint builds on the patent infringement suit filed in federal district court on May 12, 2026, and is based on Nanomics' infringement of U.S. Patent Nos. 11,435,360, 11,630,112,…- benzinga.com Seer Rejects Proposed $2.40/Share Acquisition Offer From Bradley L. Radoff And Michael Torok Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors (the "Board") has thoroughly reviewed and unanimously…
benzinga.com Radoff-JEC Group Submits Third Offer To Acquire Seer For $2.40 Per Share In Cash Plus One Contingent Value Right May 14, 2026Seer, Inc.3800 Bridge Parkway, Suite 102Redwood City, California 94065Attn: Board of DirectorsDear Members of the Board,As you are aware, Bradley L. Radoff and Michael Torok (together…- benzinga.com Seer Affirms FY2026 Sales Guidance of $16.000M-$18.000M vs $17.050M Est Seer (NASDAQ:SEER) affirms FY2026 sales outlook from $16.000 million-$18.000 million to $16.000 million-$18.000 million vs $17.050 million estimate.
- benzinga.com Full Transcript: Seer Q1 2026 Earnings Call
- benzinga.com Seer Q1 EPS $(0.30) Misses $(0.29) Estimate, Sales $2.793M Miss $3.600M Estimate Seer (NASDAQ:SEER) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.29) by 3.45 percent. This is a 11.76 percent increase over losses of $(0.34) per…
benzinga.com Earnings Scheduled For May 13, 2026 - benzinga.com Seer Files Patent Infringement Suit Against Nanomics Biotechnology Seer defends its pioneering Proteograph® Product Suite intellectual property (IP)REDWOOD CITY, Calif., May 13, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (NASDAQ:SEER), a pioneer and trusted partner for…
- benzinga.com Canaccord Genuity Initiates Coverage On Seer with Buy Rating, Announces Price Target of $4 Canaccord Genuity analyst Kyle Mikson initiates coverage on Seer (NASDAQ:SEER) with a Buy rating and announces Price Target of $4.
- benzinga.com Seer Announces That Its Board Reviewed And Unanimously Rejected The Revised Unsolicited, Non-Binding Proposal From Radoff-JEC Group Seer, Inc. (NASDAQ:SEER) ("Seer" or the "Company"), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors (the "Board") has thoroughly…
- benzinga.com Seer Announces Nonbinding Takeover Proposal From Shareholder Radoff-JEC Group At $2.35 Per Share In Cash Plus One Contingent Value Right Dear Members of the Board,As you are aware, Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group" or "we") are significant stockholders of Seer, Inc.…
benzinga.com Seer Shares Jump On Takeover Proposal Seer, Inc. (NASDAQ:SEER) shares are trading higher Monday after the company announced that the Radoff-JEC Group submitted a non-binding proposal to acquire the company.
benzinga.com Seer Joins Thermo Fisher Tools In Large-Scale Proteomics Effort Seer Proteograph platform joins Singapore study to profile 10,000 samples, integrating data for disease research and risk modeling.- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Seer Q4 Earnings Summary & Key Takeaways - benzinga.com Seer Q4 EPS $(0.29) Beats $(0.32) Estimate, Sales $4.201M Miss $4.600M Estimate Seer (NASDAQ:SEER) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.32) by 9.38 percent. This is a 21.62 percent increase over losses of $(0.37) per…
- benzinga.com Earnings Scheduled For February 26, 2026
- benzinga.com Seer Board Receives Critical Open Letter From Shareholders After 96% Share Price Decline Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group"), who collectively own nearly 7.5% of the outstanding common stock of Seer, criticized the…
- benzinga.com Seer Affirms FY2025 Sales Guidance of $17.000M-$18.000M vs $17.500M Est Seer (NASDAQ:SEER) affirms FY2025 sales outlook from $17.000 million-$18.000 million to $17.000 million-$18.000 million vs $17.500 million estimate.
- benzinga.com Seer Q3 EPS $(0.32) Misses $(0.31) Estimate, Sales $4.121M Beat $4.000M Estimate Seer (NASDAQ:SEER) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.31) by 3.23 percent. This is a 8.57 percent increase over losses of $(0.35) per…
benzinga.com Earnings Scheduled For November 6, 2025 - benzinga.com Seer Demonstrates How Proteograph Platform Advances Disease Research at American Society of Human Genetics Meeting Seer, Inc. (NASDAQ:SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced its participation at the upcoming American Society of Human Genetics (ASHG) 2025…
- benzinga.com Seer Affirms FY2025 Sales Guidance of $17.000M-$18.000M vs $17.650M Est Seer (NASDAQ:SEER) affirms FY2025 sales outlook from $17.000 million-$18.000 million to $17.000 million-$18.000 million vs $17.650 million estimate.
- benzinga.com Seer Q2 EPS $(0.33) Beats $(0.37) Estimate, Sales $4.10M Beat $3.75M Estimate Seer (NASDAQ:SEER) reported quarterly losses of $(0.33) per share which beat the analyst consensus estimate of $(0.37) by 10.81 percent. This is a 5.71 percent increase over losses of $(0.35) per…
- benzinga.com Earnings Scheduled For August 6, 2025
- benzinga.com Reported June 1, 2025: Seer And Korea University Launch Large-Scale Study Using Proteograph ONE Assay And Mass Spectrometry To Identify Early-Onset Cancer Biomarkers In Young Adults First-of-its-kind study will use Seer's next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomicsSeer's new Proteograph ONE Assay…
- benzinga.com Earnings Scheduled For May 13, 2025